Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4541175011 | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4541176012 | Monoclonal antibody antineoplastic agent | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Is a | Medicinal product acting as antineoplastic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Is a | Product containing monoclonal antibody | true | Inferred relationship | Existential restriction modifier | ||
| Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Has active ingredient | Monoclonal antibody | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing enfortumab vedotin (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing isatuximab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing sacituzumab govitecan (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing trastuzumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing ibritumomab tiuxetan | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing gemtuzumab ozogamicin | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing alemtuzumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing tositumomab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing cetuximab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing bevacizumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing panitumumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing zanolimumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing oregovomab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing naptumomab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing ofatumumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing nivolumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing pertuzumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing ramucirumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing ipilimumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing brentuximab vedotin | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing atezolizumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing avelumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing pembrolizumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing olaratumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing durvalumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing dinutuximab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing inotuzumab ozogamicin | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing mogamulizumab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing blinatumomab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing polatuzumab vedotin (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing obinutuzumab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing rituximab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing moxetumomab pasudotox (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing necitumumab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing daratumumab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing elotuzumab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing cemiplimab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing tafasitamab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing belantamab mafodotin (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing naxitamab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing margetuximab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing trastuzumab deruxtecan (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing dostarlimab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing loncastuximab tesirine (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing trastuzumab emtansine (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing amivantamab (medicinal product) | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Teclistamab | Is a | True | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR